CD38 and acute myeloid leukemia: Our study corroborated these findings; the TIM-3+ frequencies in CD34+, CD34+CD38−, and CD34+CD38+ cells were comparable between t(8;21) and inv(16) subtypes, with both subtypes showing significantly higher levels than non-CBF-AML patients.